MA26433A1 - Derives de pyridylpyrrole, procede pour leur preparation et compositions pharmaceutiques les contenant - Google Patents

Derives de pyridylpyrrole, procede pour leur preparation et compositions pharmaceutiques les contenant

Info

Publication number
MA26433A1
MA26433A1 MA24709A MA24709A MA26433A1 MA 26433 A1 MA26433 A1 MA 26433A1 MA 24709 A MA24709 A MA 24709A MA 24709 A MA24709 A MA 24709A MA 26433 A1 MA26433 A1 MA 26433A1
Authority
MA
Morocco
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
pyridylpyrrole
derivatives
Prior art date
Application number
MA24709A
Other languages
English (en)
Inventor
Kawai Akiyoshi
Kawai Makoto
Murata Yoshinori
Takada Junji
Sakakibara Minoru
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MA26433A1 publication Critical patent/MA26433A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
MA24709A 1996-07-11 1997-07-08 Derives de pyridylpyrrole, procede pour leur preparation et compositions pharmaceutiques les contenant MA26433A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IB9600671 1996-07-11

Publications (1)

Publication Number Publication Date
MA26433A1 true MA26433A1 (fr) 2004-12-20

Family

ID=11004451

Family Applications (1)

Application Number Title Priority Date Filing Date
MA24709A MA26433A1 (fr) 1996-07-11 1997-07-08 Derives de pyridylpyrrole, procede pour leur preparation et compositions pharmaceutiques les contenant

Country Status (14)

Country Link
US (1) US6417202B1 (fr)
EP (1) EP0912548A1 (fr)
AP (1) AP9701041A0 (fr)
AR (1) AR007828A1 (fr)
AU (1) AU3044197A (fr)
BR (1) BR9710352A (fr)
CA (1) CA2260213C (fr)
HN (1) HN1997000090A (fr)
HR (1) HRP970378A2 (fr)
ID (1) ID19476A (fr)
MA (1) MA26433A1 (fr)
PA (1) PA8432901A1 (fr)
TN (1) TNSN97119A1 (fr)
WO (1) WO1998002430A1 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6608060B1 (en) 1996-12-18 2003-08-19 Vertex Pharmaceuticals Incorporated Inhibitors of p38
US6147080A (en) * 1996-12-18 2000-11-14 Vertex Pharmaceuticals Incorporated Inhibitors of p38
US5945418A (en) * 1996-12-18 1999-08-31 Vertex Pharmaceuticals Incorporated Inhibitors of p38
PT853083E (pt) * 1997-01-06 2001-12-28 Pfizer Composto de piridilfurano e piridiltiofeno e sua utilizacao farmaceutica
FR2771412B1 (fr) * 1997-11-26 2000-04-28 Adir Nouveaux derives de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU1890299A (en) * 1998-01-14 1999-08-02 Nippon Shinyaku Co. Ltd. Potassium channel activators
WO1999061016A1 (fr) * 1998-05-27 1999-12-02 Nippon Shinyaku Co., Ltd. Inhibiteurs de cyclo-oxygenase-2
AU4315100A (en) * 1999-04-28 2000-11-17 Sankyo Company Limited Preventive or inhibitory agents for hepatopathy
WO2000069847A1 (fr) * 1999-05-14 2000-11-23 Ortho-Mcneil Pharmaceutical, Inc. 3-pyridyle-4-arylpyrroles substitues et methodes prophylactiques et therapeutiques associees
WO2001030757A1 (fr) * 1999-10-28 2001-05-03 Microcide Pharmaceuticals, Inc. Inhibiteurs de la pompe par liberation de medicaments
GB0003154D0 (en) * 2000-02-12 2000-04-05 Astrazeneca Uk Ltd Novel compounds
GB0016453D0 (en) * 2000-07-04 2000-08-23 Hoffmann La Roche Pyrrole derivatives
CA2435141A1 (fr) * 2001-01-18 2002-07-25 Sankyo Company, Limited Compositions destinees a la prevention et au traitement de l'hepatopathie
US7056917B2 (en) * 2001-04-26 2006-06-06 Daiichi Pharmaceutical Co., Ltd. Drug efflux pump inhibitor
EP1389463A4 (fr) * 2001-04-26 2008-09-17 Daiichi Seiyaku Co Medicament permettant d'inhiber une pompe d'elimination de medicament
SE0102617D0 (sv) 2001-07-25 2001-07-25 Astrazeneca Ab Novel compounds
SE0102616D0 (sv) 2001-07-25 2001-07-25 Astrazeneca Ab Novel compounds
AU2002331179B2 (en) 2001-08-30 2008-04-17 F. Hoffmann-La Roche Ag Aminopyrrole compounds as antiinflammatory agents
AU2003301226A1 (en) * 2002-12-20 2004-07-22 Pharmacia Corp Acyclic pyrazole compounds for the inhibition of mitogen activated protein kinase-activated protein kinase-2
SE0300092D0 (sv) 2003-01-15 2003-01-15 Astrazeneca Ab Novel compounds
SE0300091D0 (sv) 2003-01-15 2003-01-15 Astrazeneca Ab Novel compounds
US20050043346A1 (en) * 2003-08-08 2005-02-24 Pharmacia Italia S.P.A. Pyridylpyrrole derivatives active as kinase inhibitors
WO2005079805A1 (fr) * 2004-02-20 2005-09-01 Astrazeneca Ab Derives de pyrrole utilises en tant qu'antagonistes de l'hormone liberant de la gonadotrophine (gnrh)
RU2448104C2 (ru) * 2005-12-19 2012-04-20 Зингента Лимитед Замещенные ароматические гетероциклические соединения, как фунгициды
US7618982B2 (en) * 2005-12-19 2009-11-17 Nerviano Medical Sciences S.R.L. Heteroarylpyrrolopyridinones active as kinase inhibitors
NZ572202A (en) 2006-03-27 2012-05-25 Nerviano Medical Sciences Srl Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
EP2069333A1 (fr) 2006-09-21 2009-06-17 Novartis Ag Derives de pyrrole utilises dans le traitement des maladies induites par les cytokines
EP2838881B1 (fr) 2012-04-20 2018-08-08 AbbVie Inc. Dérivés d'iso-indolone
CN104379573A (zh) * 2012-04-20 2015-02-25 艾伯维公司 异吲哚酮衍生物
WO2014165127A1 (fr) * 2013-03-12 2014-10-09 Abbvie Inc. Inhibiteurs de pyrrole-amide
WO2015193339A1 (fr) 2014-06-17 2015-12-23 Bayer Pharma Aktiengesellschaft 3-amino -1,5,6,7-tétrahydro-4 h-indol-4-ones
WO2017102649A1 (fr) * 2015-12-16 2017-06-22 Bayer Pharma Aktiengesellschaft Hétéro-1,5,6,7-tétrahydro-4h-indol-4-ones

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356897A (en) * 1991-09-09 1994-10-18 Fujisawa Pharmaceutical Co., Ltd. 3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines
AU705082B2 (en) * 1995-08-10 1999-05-13 Merck & Co., Inc. 2-substituted aryl pyrroles, compositions containing such compounds and methods of use
CA2228050A1 (fr) 1995-08-10 1997-02-20 Harold G. Selnick Pyrroles d'aryle substitues en position 2 et 5, compositions contenant de tels composes et leurs modes d'utilisation
JPH11514651A (ja) * 1995-10-31 1999-12-14 メルク エンド カンパニー インコーポレーテッド 置換ピリジルピロール、前記化合物を含む組成物及び使用方法
AU7529096A (en) 1995-10-31 1997-05-22 Merck & Co., Inc. Substituted aryl pyrroles, compositions containing such compounds and methods of use
WO1997016441A1 (fr) 1995-10-31 1997-05-09 Merck & Co., Inc. Pyrroles aryliques de substitution, compositions renfermant de telles composes et methodes d'utilisation de ces substances
US5776954A (en) * 1996-10-30 1998-07-07 Merck & Co., Inc. Substituted pyridyl pyrroles, compositions containing such compounds and methods of use

Also Published As

Publication number Publication date
HN1997000090A (es) 1997-12-26
PA8432901A1 (es) 2000-05-24
AR007828A1 (es) 1999-11-24
WO1998002430A1 (fr) 1998-01-22
ID19476A (id) 1998-07-16
US20020049235A1 (en) 2002-04-25
TNSN97119A1 (fr) 2005-03-15
BR9710352A (pt) 1999-08-17
AU3044197A (en) 1998-02-09
AP9701041A0 (en) 1999-01-10
CA2260213C (fr) 2005-03-29
EP0912548A1 (fr) 1999-05-06
CA2260213A1 (fr) 1998-01-22
US6417202B1 (en) 2002-07-09
HRP970378A2 (en) 1998-08-31

Similar Documents

Publication Publication Date Title
MA26433A1 (fr) Derives de pyridylpyrrole, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26424A1 (fr) Derives de 6-phenylpyridyl-2-amine, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26472A1 (fr) Derives de n-hydroxy-b-sulfonylpropionamide, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26479A1 (fr) Derives de nicotinamide, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26468A1 (fr) Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26432A1 (fr) Derives de 2-(2-oxo-ethylidene)-imidazolidine-4-one, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26686A1 (fr) Derives de 4,4-biarylpiperidine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26425A1 (fr) Derives de lactames, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2780057B1 (fr) Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26438A1 (fr) Derives 6,5-heterobicycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26687A1 (fr) 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2740136B1 (fr) Derives d'indolin-2-one, procede pour leur preparation et les compositions pharmaceutiques les contenant
FR2735777B1 (fr) Derives de 4-phenylaminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
MA26559A1 (fr) Derives de d-proline, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation
MA26465A1 (fr) Derives de quinoleine et derives de quinazoline nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26680A1 (fr) Derives de quinoleine-2-one a substituant alcynyle nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26499A1 (fr) Derives de tetrazole, procede pour leur preparation et compositions pharmaceutiques les contenant .
MA26526A1 (fr) Derives d'indole inhibiteurs de cyclo-oxygenase, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26439A1 (fr) Derives d'indazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26414A1 (fr) Derives de quinoleine et de quinazoline nouveaux, procede pour leur preparation et formulations pharmaceutiques les contenant.
MA26505A1 (fr) Derives de 6-o-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26558A1 (fr) Derives nouveaux de 6-0-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA23831A1 (fr) Derives de quinazoline, procede pour leur preparation et composition les contenant
MA26471A1 (fr) Derives d'acide arylsulfonylaminohydroxamique, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26624A1 (fr) Derives de quinazolinamines nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant